AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS

Go back to AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS

Amgen (AMGN) Tops Q1 EPS by 15c, Offers Guidance

April 27, 2022 4:02 PM EDT

Amgen (NASDAQ: AMGN) reported Q1 EPS of $4.25, $0.15 better than the analyst estimate of $4.10. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.07 billion.

GUIDANCE:

Amgen sees FY2022 EPS of $17.00-$18.00, versus the consensus of $17.63. Amgen sees... More